JUL 01, 2016 01:07 PM PDT

Stronger Immune Response to Ward Off Tuberculosis

WRITTEN BY: Kara Marker
Autophagy is a natural process that occurs in the body to remove defective proteins, potentially misfolded or aggregated, from the body to make remove for important, intact sources of energy. In search for a new treatment for tuberculosis that bypasses the growing problem of antibiotic resistance, researchers from Linkoping University are thinking of harnessing the power of autophagy, but there are still a few bumps in the road to resolve.
 Credit: Medical News Today
Tuberculosis (TB) is caused by a bacterium, making antibiotics the primary method of treating infections. However, like many other bacteria species, Mycobacterium tuberculosis finds ways to evolve and become resistant to drugs that target its cellular processes. TB most often affects the lungs, but other parts of the body can be attacked as well. Symptoms of TB usually include a bad, persistent cough, chest pain, and coughing up blood and phlegm. Without treatment, TB is deadly.
 
Isoniazid and rifampicin are two common drugs used to treat TB, but many strains of M. tuberculosis are quickly becoming resistant to these two antibiotics. As an alternative, second-line drugs like amikacin and kanamycin can be used to treat TB, unless the strain if extensively drug-resistant (XDR TB). The more resistant M. tuberculosis bacteria become to existing antibiotics, the more toxic and harmful drugs that are effective will become. That is unless, the researchers from Linkoping University can learn to safely use autophagy as a way to kill TB bacteria.
 
The adapted form of autophagy, called stimulated autophagy, can be very dangerous, mainly when a TB patient also has HIV or when the TB infection is in its first stages where the amount of bacterial colonies is low. When used in these instances, stimulated autophagy actually leads to increased multiplication of bacterial colonies within host cells. When stimulated autophagy is approved to be used, it usually exists in the form of inhibiting a mammalian target of rapamycin complex-1 (mTORC1).
 
For now, finding the “sweet spot” of safe stimulated autophagy will work for patients with aggressive TB infections and those without HIV. However, to address the other two groups, scientists will have to pick apart what causes stimulated autophagy to worsen cases of tuberculosis in these patients. “If this is taken into consideration when new medicines are tested, setbacks could be prevented,” said Robert Blomgran, a research fellow in medicinal microbiology at Linkoping University.
 
This study was recently published in the journal Nature Immunology.
 

 
Sources: Linkoping University,  The Journal of Pathology, Centers for Disease Control and Prevention, National Institute of Allergy and Infectious Diseases, Nature Communications
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 16, 2019
Health & Medicine
SEP 16, 2019
Tick-Borne Diseases Are Rapidly Rising in the U.S.
Tick-borne diseases have significantly increased in the U.S. in the past few years. In 2016 there were 48,610 reported cases and in 2017 59,349; these...
SEP 16, 2019
Immunology
SEP 16, 2019
Fecal Transplant improves ASD
Our understanding of the brain-gut connection is increasing by the day. Individuals with autism spectrum disorder (ASD) also experience gastrointestinal sy...
SEP 16, 2019
Microbiology
SEP 16, 2019
Dengue Vaccine Reaches the Clinic, with Restrictions
Dengue fever is an unusual virus that presented complications for the recently-developed and first vaccine for the disease....
SEP 16, 2019
Microbiology
SEP 16, 2019
Altering the Gut Microbiome Relieves Alzheimer's Symptoms in Mice
A link between the gut microbiome and Alzheimer's disease may help researchers treat the disease....
SEP 16, 2019
Cardiology
SEP 16, 2019
Strep Throat Can Lead To Heart Complications
Rheumatic fever (RF) is a complication resulting from untreated strep throat. Caused by group A streptococcal infection, rheumatic fever was once the numbe...
SEP 16, 2019
Immunology
SEP 16, 2019
Are Bacteria Fighting Cancer For Us?
Scientists at the Sanford Burnham Prebys Medical Discovery Institute found that the RNF5 enzyme, produced by a gene in gut microbes affects tumor growth.&n...
Loading Comments...